Cargando…

Austrian Syndrome and Multiple Myeloma: A Fatal Combination

Detalles Bibliográficos
Autores principales:	Baig, Abdur, Moskovits, Manfred, Herrold, Edmund M, Borra, Sonia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2012
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3482791/ https://www.ncbi.nlm.nih.gov/pubmed/23112981 http://dx.doi.org/10.4103/1947-2714.102014

Ejemplares similares

A Case of Fatal Hyperammonaemic Encephalopathy in a Patient with End-Stage Multiple Myeloma
por: Passucci, Mauro, et al.
Publicado: (2023)

An Unconventional Presentation of Multiple Myeloma: Bazex Syndrome
por: Kandemir Alibakan, Özlem, et al.
Publicado: (2020)

Austrian Syndrome Associated with Pandemic (H1N1) 2009 in Child
por: Alhushki, Waseem, et al.
Publicado: (2010)

Near-Fatal Multiple Organ Dysfunction Syndrome Induced by Plasmodium malariae
por: Descheemaeker, Pierre-Néri, et al.
Publicado: (2009)

Incidences of Fatalities on Austrian Ski Slopes: A 10-Year Analysis
por: Posch, Markus, et al.
Publicado: (2020)

Multiple Myeloma and Alkaline Phosphatase
por: Yavaşoğlu, İrfan, et al.
Publicado: (2015)

Indatuximab ravtansine (BT062) combination treatment in multiple myeloma: pre-clinical studies
por: Schönfeld, Kurt, et al.
Publicado: (2017)

Imported Fatal Hantavirus Pulmonary Syndrome
por: Reynolds, Steven, et al.
Publicado: (2007)

Carbamazepine and Multiple Myeloma: Possible Interaction
por: Günaldı, Meral, et al.
Publicado: (2013)

Daratumumab in dialysis-dependent multiple myeloma
por: Jeyaraman, Preethi, et al.
Publicado: (2020)

Pooled analysis of the reports of carfilzomib, panobinostat, and elotuzumab combinations in patients with refractory/relapsed multiple myeloma
por: Liu, Liping, et al.
Publicado: (2016)

Oligosecretory multiple myeloma: a case report
por: Khurana, Ujjawal, et al.
Publicado: (2016)

Talquetamab: A promising immunotherapy for multiple myeloma
por: Tariq, Amna, et al.
Publicado: (2023)

Fatal Systemic Capillary Leak Syndrome after SARS-CoV-2Vaccination in Patient with Multiple Myeloma
por: Choi, Gwang-Jun, et al.
Publicado: (2021)

Evolving therapeutic role of bisphosphonates in multiple myeloma
por: Ural, A U, et al.
Publicado: (2005)

Multiple myeloma presenting with focal segmental glomerulosclerosis
por: Valizadeh, Nasim, et al.
Publicado: (2013)

The Coexistence of Chronic Lymphocytic Leukemia and Multiple Myeloma
por: Hangül, Ceren, et al.
Publicado: (2019)

Renal cell carcinoma concomitant with multiple myeloma
por: Narwal, Anubhav, et al.
Publicado: (2022)

Trends of survival in patients with multiple myeloma in Japan: a multicenter retrospective collaborative study of the Japanese Society of Myeloma
por: Ozaki, S, et al.
Publicado: (2015)

Multiple myeloma and fever of unknown origin: a need for therapy
por: Mumoli, N, et al.
Publicado: (2005)

Nonsecretory multiple myeloma, how to make a diagnosis?
por: Wiwanitkit, Viroj
Publicado: (2010)

Empyema Necessitans: An Unexpected Infectious Presentation of Multiple Myeloma
por: Kapila, Aaysha, et al.
Publicado: (2017)

Catastrophic antiphospholipid syndrome (CAPS): A rare and fatal encounter
por: Mehta, Jayant K.
Publicado: (2015)

A Very Rare Unexpected Fatal Complication of Nephrotic Syndrome
por: Etta, Praveen Kumar, et al.
Publicado: (2019)

Prevalence, incidence and survival of smoldering multiple myeloma in the United States
por: Ravindran, A, et al.
Publicado: (2016)

A case of synchronous multiple myeloma and chronic myeloid leukemia
por: Lee, Ji-Young, et al.
Publicado: (2017)

IgA nephropathy in IgG kappa multiple myeloma
por: Couto, Maria Eduarda, et al.
Publicado: (2021)

“A beacon of hope for relapsed multiple myeloma patients: TALVEY™”
por: Khaliq, Nawal, et al.
Publicado: (2023)

Fatal acute hepatorenal failure during antimalarial-based combination treatment
por: Gnionsahé, Apollinaire, et al.
Publicado: (2010)

Fatal post-operative venous thromboembolism in an adult with Down syndrome
por: Vadhanan, Prasanna, et al.
Publicado: (2022)

Identifying the link between multiple myeloma and neurofibromatosis type I
por: Rago, Angela, et al.
Publicado: (2020)

The Outcome of Six Patients with COVID-19 Infection and Multiple Myeloma
por: Elsabah, Hesham, et al.
Publicado: (2020)

WDR26 and MTF2 are therapeutic targets in multiple myeloma
por: Sun, Fumou, et al.
Publicado: (2021)

Cutaneous secondary localization of multiple myeloma at Heparin injection sites
por: Borg, Emma, et al.
Publicado: (2023)

Elrexfio™ (elranatamab-bcmm): The game-changer in treatment of multiple myeloma
por: Rais, Taruba, et al.
Publicado: (2023)

Chemotherapy in solitary bone plasmacytoma to prevent evolution to multiple myeloma
por: Ascione, Sophia, et al.
Publicado: (2023)

Cardiac complications in relapsed and refractory multiple myeloma patients treated with carfilzomib
por: Atrash, S, et al.
Publicado: (2015)

Hypoxia promotes stem cell-like phenotype in multiple myeloma cells
por: Muz, B, et al.
Publicado: (2014)

Baclofen-Related Neurotoxicity: Implication in a Fatality Associated With Hepatorenal Syndrome
por: Golightly, Larry K, et al.
Publicado: (2017)

Fatal Ventricular Fibrillation Storm in a Young Patient with Marfan Syndrome
por: Shitara, Jun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ta3q7qrm0a7jephuc6ufdljmc5